Skip to main content

Madrigal Pharmaceuticals, Inc.

MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001157601

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of MDGL: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders137151+14
Shares12.2M11.2M−981.2K (−8.0%)
Value$1.43B$1.09B−$334.0M (−23.4%)

New holders (31)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to MDGL in Q2 2021
InstitutionSharesValue% of portfolio
Marshall Wace, LLP98,180$9.56M0.05%
Marshall Wace North America L.P.95,380$9.29M0.04%
Maven Securities LTD50,000$4.91M0.52%
Polar Asset Management Partners Inc.28,100$2.74M0.03%
Cubist Systematic Strategies, LLC27,664$2.69M0.03%
State of New Jersey Common Pension Fund D18,627$1.81M0.01%
Duality Advisers, LP17,535$1.71M0.15%
HRT Financial LP10,759$1.05M0.01%
Engineers Gate Manager LP6,002$585.0K0.04%
Federated Hermes, Inc.5,902$575.0K0.00%
Gsa Capital Partners LLP5,003$487.0K0.05%
Meeder Asset Management Inc3,364$328.0K0.02%
Capula Management Ltd3,248$316.0K0.06%
SEI Investments Co2,977$290.0K0.00%
Verition Fund Management LLC2,815$274.0K0.00%
Martingale Asset Management L P2,603$254.0K0.00%
Silverarc Capital Management, LLC2,480$242.0K0.13%
Dynamic Technology Lab Private Ltd2,230$217.0K0.02%
Twinbeech Capital LP2,188$213.0K0.03%
Amalgamated Bank2,145$209.0K0.00%
Trexquant Investment LP2,080$203.0K0.02%
Exane Derivatives1,418$143.1K0.03%
Point72 Hong Kong Ltd1,445$141.0K0.01%
Optiver Holding B.V.1,072$104.0K0.01%
FORA Capital, LLC543$53.0K0.01%
Quantbot Technologies LP238$23.0K0.00%
McIlrath & Eck, LLC52$5.00K0.00%
Geneos Wealth Management Inc.50$4.00K0.00%
IFP Advisors, Inc1$00.00%
Parallel Advisors, LLC2$00.00%
Berman Capital Advisors, LLC9$00.00%

Sold out (17)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.